Medication

AAD: Zasocitinib Safe, Effective for Moderate-to-Severe Plaque Psoriasis in Adults

Physician’s Briefing

AAD: Zasocitinib Safe, Effective for Moderate-to-Severe Plaque Psoriasis in Adults

03 Apr 2026

2 min read

AAD: Significant Benefits Seen for Brepocitinib 30 mg in Dermatomyositis

Physician’s Briefing

AAD: Significant Benefits Seen for Brepocitinib 30 mg in Dermatomyositis

01 Apr 2026

2 min read

Review Identifies Different Approaches to Prevent Nephrolithiasis

Physician’s Briefing

Review Identifies Different Approaches to Prevent Nephrolithiasis

24 Mar 2026

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com